Thalassemia

Gene Therapy May Eliminate Blood Transfusion Needs in Severe β-Thalassemia

Gene Therapy May Eliminate Blood Transfusion Needs in Severe β-Thalassemia

By

With use of CD34+ cells via BB305 vector transduction, patients with severe β-thalassemia may no longer require long-term RBC transfusions as frequently or at all.

Sign Up for Free e-newsletters